Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Khojasteh Shirkhani

PhD


Clinical Project Manager

I currently work as a Clinical Project Manager within Professor Adrian Hill’s pre-erythrocytic malaria vaccine group at the Jenner Institute. My role involves providing management support for a new vaccine programme focused on exploring innovative administration regimens for R21, the leading malaria vaccine candidate.

Before this position, I worked as a Clinical Translational Scientist at OxfordBiomedica, where I played a role in supporting and managing the development of cell and gene therapeutic products across various clinical trial phases using bioanalytical assays.

Prior to my role at OxfordBiomedica, I served as a Technical Project Manager at Catalent Pharma Solution. During this time, I led the MACIVIVA project, which aimed to develop a virosome-based vaccine formulation for sublingual delivery targeting HIV.

Before transitioning into Industry, I pursued my Ph.D. in Drug Discovery at Imperial College London.